Logo image of GEVO

GEVO INC (GEVO) Stock Fundamental Analysis

NASDAQ:GEVO - Nasdaq - US3743964062 - Common Stock - Currency: USD

1.255  -0.05 (-3.46%)

Fundamental Rating

2

Taking everything into account, GEVO scores 2 out of 10 in our fundamental rating. GEVO was compared to 213 industry peers in the Oil, Gas & Consumable Fuels industry. GEVO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, GEVO is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year GEVO has reported negative net income.
In the past year GEVO has reported a negative cash flow from operations.
In the past 5 years GEVO always reported negative net income.
In the past 5 years GEVO always reported negative operating cash flow.
GEVO Yearly Net Income VS EBIT VS OCF VS FCFGEVO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -12.02%, GEVO is doing worse than 86.39% of the companies in the same industry.
GEVO has a worse Return On Equity (-17.34%) than 78.87% of its industry peers.
Industry RankSector Rank
ROA -12.02%
ROE -17.34%
ROIC N/A
ROA(3y)-12.55%
ROA(5y)-14.65%
ROE(3y)-14.71%
ROE(5y)-16.48%
ROIC(3y)N/A
ROIC(5y)N/A
GEVO Yearly ROA, ROE, ROICGEVO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60

1.3 Margins

GEVO has a Gross Margin of 20.65%. This is in the lower half of the industry: GEVO underperforms 66.20% of its industry peers.
The Profit Margin and Operating Margin are not available for GEVO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.65%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GEVO Yearly Profit, Operating, Gross MarginsGEVO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K -10K

More info and screens

4

2. Health

2.1 Basic Checks

GEVO does not have a ROIC to compare to the WACC, probably because it is not profitable.
GEVO has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, GEVO has more shares outstanding
The debt/assets ratio for GEVO is higher compared to a year ago.
GEVO Yearly Shares OutstandingGEVO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
GEVO Yearly Total Debt VS Total AssetsGEVO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of -1.03, we must say that GEVO is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of GEVO (-1.03) is worse than 76.06% of its industry peers.
GEVO has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of GEVO (0.31) is better than 60.56% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z -1.03
ROIC/WACCN/A
WACC8.53%
GEVO Yearly LT Debt VS Equity VS FCFGEVO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

GEVO has a Current Ratio of 2.04. This indicates that GEVO is financially healthy and has no problem in meeting its short term obligations.
GEVO has a Current ratio of 2.04. This is in the better half of the industry: GEVO outperforms 77.93% of its industry peers.
A Quick Ratio of 1.71 indicates that GEVO should not have too much problems paying its short term obligations.
GEVO has a Quick ratio of 1.71. This is in the better half of the industry: GEVO outperforms 76.06% of its industry peers.
Industry RankSector Rank
Current Ratio 2.04
Quick Ratio 1.71
GEVO Yearly Current Assets VS Current LiabilitesGEVO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

5

3. Growth

3.1 Past

GEVO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -24.14%.
GEVO shows a strong growth in Revenue. In the last year, the Revenue has grown by 145.35%.
The Revenue has been decreasing by -7.13% on average over the past years.
EPS 1Y (TTM)-24.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-12.5%
Revenue 1Y (TTM)145.35%
Revenue growth 3Y217.2%
Revenue growth 5Y-7.13%
Sales Q2Q%629.55%

3.2 Future

The Earnings Per Share is expected to grow by 29.94% on average over the next years. This is a very strong growth
GEVO is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 74.20% yearly.
EPS Next Y28.31%
EPS Next 2Y32.15%
EPS Next 3Y16.77%
EPS Next 5Y29.94%
Revenue Next Year1131.25%
Revenue Next 2Y271.78%
Revenue Next 3Y143.42%
Revenue Next 5Y74.2%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GEVO Yearly Revenue VS EstimatesGEVO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M 400M 500M
GEVO Yearly EPS VS EstimatesGEVO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 -1K -2K -3K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

GEVO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year GEVO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GEVO Price Earnings VS Forward Price EarningsGEVO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GEVO Per share dataGEVO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as GEVO's earnings are expected to grow with 16.77% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.15%
EPS Next 3Y16.77%

More info and screens

0

5. Dividend

5.1 Amount

GEVO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GEVO INC

NASDAQ:GEVO (6/25/2025, 3:59:00 PM)

1.255

-0.05 (-3.46%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-13 2025-05-13/amc
Earnings (Next)08-06 2025-08-06/amc
Inst Owners24.32%
Inst Owner Change11.54%
Ins Owners3.83%
Ins Owner Change7.02%
Market Cap300.65M
Analysts78
Price Target4.97 (296.02%)
Short Float %13.28%
Short Ratio9.63
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-21.22%
Min EPS beat(2)-49.55%
Max EPS beat(2)7.12%
EPS beat(4)1
Avg EPS beat(4)-18.67%
Min EPS beat(4)-49.55%
Max EPS beat(4)7.12%
EPS beat(8)1
Avg EPS beat(8)-20.88%
EPS beat(12)2
Avg EPS beat(12)-34.71%
EPS beat(16)2
Avg EPS beat(16)-29.7%
Revenue beat(2)2
Avg Revenue beat(2)43.72%
Min Revenue beat(2)41.02%
Max Revenue beat(2)46.42%
Revenue beat(4)3
Avg Revenue beat(4)10.15%
Min Revenue beat(4)-64.45%
Max Revenue beat(4)46.42%
Revenue beat(8)5
Avg Revenue beat(8)4.83%
Revenue beat(12)6
Avg Revenue beat(12)-12.07%
Revenue beat(16)7
Avg Revenue beat(16)-13.84%
PT rev (1m)-6.47%
PT rev (3m)-15.77%
EPS NQ rev (1m)-5.45%
EPS NQ rev (3m)-16%
EPS NY rev (1m)12.14%
EPS NY rev (3m)12.14%
Revenue NQ rev (1m)-1.94%
Revenue NQ rev (3m)26.83%
Revenue NY rev (1m)53.43%
Revenue NY rev (3m)20.99%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.15
P/FCF N/A
P/OCF N/A
P/B 0.64
P/tB 0.8
EV/EBITDA N/A
EPS(TTM)-0.36
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS0.18
BVpS1.96
TBVpS1.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.02%
ROE -17.34%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.65%
FCFM N/A
ROA(3y)-12.55%
ROA(5y)-14.65%
ROE(3y)-14.71%
ROE(5y)-16.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 202.41%
Cap/Sales 93.75%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.04
Quick Ratio 1.71
Altman-Z -1.03
F-Score4
WACC8.53%
ROIC/WACCN/A
Cap/Depr(3y)508.76%
Cap/Depr(5y)546.58%
Cap/Sales(3y)2347.16%
Cap/Sales(5y)3571.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-24.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-12.5%
EPS Next Y28.31%
EPS Next 2Y32.15%
EPS Next 3Y16.77%
EPS Next 5Y29.94%
Revenue 1Y (TTM)145.35%
Revenue growth 3Y217.2%
Revenue growth 5Y-7.13%
Sales Q2Q%629.55%
Revenue Next Year1131.25%
Revenue Next 2Y271.78%
Revenue Next 3Y143.42%
Revenue Next 5Y74.2%
EBIT growth 1Y6.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year111%
EBIT Next 3Y39.82%
EBIT Next 5Y27.29%
FCF growth 1Y9.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-9.71%
OCF growth 3YN/A
OCF growth 5YN/A